To see if using both CRP and IP-10 (one after the other) for TB screening will lead to better performance of the biomarkers as a screening tool for active TB, we assessed the performance of the combination of each cut-off point of CRP with each of the cut-off points of IP-10. This evidence concerns the gene CRP and tuberculosis.